They sacked the doc did they after his faux pas?
We will just ignore Japan sales and free use in the USA meanwhile plus the plethora of stem cell clinics around the world. No mention of the back pain trial data success? No mention of the likely income from same?
Sad if you are the best they can get.
- Forums
- ASX - By Stock
- Ann: FDA Grants Orphan Drug Designation for Revascor
They sacked the doc did they after his faux pas?We will just...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.58 |
Change
0.005(0.32%) |
Mkt cap ! $1.798B |
Open | High | Low | Value | Volume |
$1.56 | $1.61 | $1.52 | $6.446M | 4.092M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 62215 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 14678 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 62215 | 1.570 |
3 | 77179 | 1.565 |
4 | 41107 | 1.560 |
1 | 11805 | 1.555 |
5 | 65792 | 1.550 |
Price($) | Vol. | No. |
---|---|---|
1.580 | 14678 | 2 |
1.590 | 12941 | 2 |
1.595 | 51292 | 6 |
1.600 | 82929 | 6 |
1.605 | 81193 | 5 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |